Human pharmaceutical products in the environment - the "problem" in perspective.

Area of Science:

• Environmental Science
• Toxicology
• Chemical Analysis

Background:

• Growing concerns regarding environmental impacts of pharmaceutical residues since the early 21st century.
• An exponential increase in research and conferences addressing pharmaceutical pollution.
• Pharmaceuticals lack uniform chemical, structural, biological, or toxicological properties, challenging their classification as a single group.

Purpose of the Study:

• To critically evaluate the scientific justification for singling out human pharmaceuticals as a primary environmental concern.
• To advocate for a broader risk assessment approach for all emerging environmental contaminants.
• To redirect research resources towards substances posing genuinely significant environmental risks.

Main Methods:

• Literature review and analysis of the scientific discourse on pharmaceutical pollution.
• Examination of the chemical and toxicological diversity of pharmaceutical substances.
• Comparative analysis of risk assessment strategies for various environmental contaminants.

Main Results:

• The intense focus on human pharmaceuticals is scientifically unjustifiable due to their heterogeneity.
• Many substances, including pharmaceuticals, may pose minimal environmental or human health risks.
• Emerging analytical techniques detect a wide range of contaminants, including pharmaceuticals, at very low concentrations (sub μgL(-1)).

Conclusions:

• Environmental contaminants, including pharmaceuticals, require individual risk assessment on a case-by-case basis.
• Treating all human pharmaceuticals as a distinct category diverts attention from potentially more significant emerging contaminants.
• A holistic approach to environmental contaminant assessment is necessary to effectively manage risks and allocate resources.